{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T15:24:26Z","timestamp":1795101866805,"version":"4.10.3"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T00:00:00Z","timestamp":1691452800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T00:00:00Z","timestamp":1691452800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"crossref","award":["BK20220469"],"award-info":[{"award-number":["BK20220469"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100010023","name":"Natural Science Research of Jiangsu Higher Education Institutions of China","doi-asserted-by":"publisher","award":["22KJB360003"],"award-info":[{"award-number":["22KJB360003"]}],"id":[{"id":"10.13039\/501100010023","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Scientific research project of Jiangsu Provincial Health Commission","award":["Z2022020"],"award-info":[{"award-number":["Z2022020"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82204934"],"award-info":[{"award-number":["82204934"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82274241"],"award-info":[{"award-number":["82274241"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Foundation of Jiangsu CM Clinical Innovation Center of Degenerative Bone & Joint Disease","award":["[2021] No. 4"],"award-info":[{"award-number":["[2021] No. 4"]}]},{"name":"Key research and development projects of Ningxia","award":["2021BEG02040"],"award-info":[{"award-number":["2021BEG02040"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The development of natural membranes as coatings for nanoparticles to traverse the blood-brain barrier (BBB) presents an effective approach for treating central nervous system (CNS) disorders. In this study, we have designed a nanogel loaded with PACAP and estrogen (E2), sheathed with exosomes and responsive to reactive oxygen species (ROS), denoted as HA NGs@exosomes. The objective of this novel design is to serve as a potent drug carrier for the targeted treatment of perimenopausal depression. The efficient cellular uptake and BBB penetration of HA NGs@exosomes has been demonstrated in vitro and in vivo. Following intranasal intervention with HA NGs@exosomes, ovariectomized mice under chronic unpredictable mild stress (CUMS) have shown improved behavioral performance, indicating that HA NGs@exosomes produced a rapid-onset antidepressant effect. Moreover, HA NGs@exosomes exhibit notable antioxidant and anti-inflammatory properties and may regulate the expression of pivotal proteins in the PACAP\/PAC1 pathway to promote synaptic plasticity. Our results serve as a proof-of-concept for the utility of exosome-sheathed ROS-responsive nanogel as a promising drug carrier for the treatment of perimenopausal depression.<\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical Abstract<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1186\/s12951-023-02005-y","type":"journal-article","created":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T04:01:57Z","timestamp":1691467317000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Exosome-sheathed ROS-responsive nanogel to improve targeted therapy in perimenopausal depression"],"prefix":"10.1186","volume":"21","author":[{"given":"Yue","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yafeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,8]]},"reference":[{"issue":"1","key":"2005_CR1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1176\/appi.ajp.2007.07071152","volume":"165","author":"BL Parry","year":"2008","unstructured":"Parry BL. Perimenopausal depression. Am J Psychiatry. 2008;165(1):23\u20137.","journal-title":"Am J Psychiatry"},{"issue":"1","key":"2005_CR2","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1001\/jamapsychiatry.2013.2819","volume":"71","author":"EW Freeman","year":"2014","unstructured":"Freeman EW, Sammel MD, Boorman DW, Zhang R. Longitudinal pattern of depressive symptoms around natural menopause. JAMA Psychiatry. 2014;71(1):36\u201343.","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"2005_CR3","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.smrv.2005.09.004","volume":"10","author":"BL Parry","year":"2006","unstructured":"Parry BL, Fernando Mart\u00ednez L, Maurer EL, L\u00f3pez AM, Sorenson D, Meliska CJ. Sleep, rhythms and women\u2019s mood. Part II. Menopause. Sleep Med Rev. 2006;10(3):197\u2013208.","journal-title":"Sleep Med Rev"},{"issue":"7","key":"2005_CR4","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1001\/jamapsychiatry.2015.0111","volume":"72","author":"PJ Schmidt","year":"2015","unstructured":"Schmidt PJ, Ben Dor R, Martinez PE, Guerrieri GM, Harsh VL, Thompson K, Koziol DE, Nieman LK, Rubinow DR. Effects of estradiol withdrawal on mood in women with past perimenopausal depression: a randomized clinical trial. JAMA Psychiatry. 2015;72(7):714\u201326.","journal-title":"JAMA Psychiatry"},{"issue":"7","key":"2005_CR5","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1001\/jamapsychiatry.2015.0487","volume":"72","author":"P Newhouse","year":"2015","unstructured":"Newhouse P, Albert K. Estrogen, stress, and Depression: a neurocognitive model. JAMA Psychiatry. 2015;72(7):727\u20139.","journal-title":"JAMA Psychiatry"},{"issue":"8","key":"2005_CR6","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1176\/appi.ajp.160.8.1519","volume":"160","author":"LS Cohen","year":"2003","unstructured":"Cohen LS, Soares CN, Poitras JR, Prouty J, Alexander AB, Shifren JL. Short-term use of estradiol for depression in perimenopausal and postmenopausal women: a preliminary report. Am J Psychiatry. 2003;160(8):1519\u201322.","journal-title":"Am J Psychiatry"},{"issue":"Suppl 4","key":"2005_CR7","first-page":"15","volume":"59","author":"SM Stahl","year":"1998","unstructured":"Stahl SM. Basic psychopharmacology of antidepressants, part 2: estrogen as an adjunct to antidepressant treatment. J Clin Psychiatry. 1998;59(Suppl 4):15\u201324.","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"2005_CR8","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1001\/jamapsychiatry.2017.3998","volume":"75","author":"JL Gordon","year":"2018","unstructured":"Gordon JL, Rubinow DR, Eisenlohr-Moul TA, Xia K, Schmidt PJ, Girdler SS. Efficacy of transdermal estradiol and micronized progesterone in the prevention of depressive symptoms in the menopause transition: a randomized clinical trial. JAMA Psychiatry. 2018;75(2):149\u201357.","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"2005_CR9","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","volume":"288","author":"JE Rossouw","year":"2002","unstructured":"Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women\u2019s Health Initiative randomized controlled trial. JAMA. 2002;288(3):321\u201333.","journal-title":"JAMA"},{"issue":"1","key":"2005_CR10","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s10549-011-1848-9","volume":"132","author":"CJ Crandall","year":"2012","unstructured":"Crandall CJ, Aragaki AK, Cauley JA, McTiernan A, Manson JE, Anderson G, Chlebowski RT. Breast tenderness and breast cancer risk in the estrogen plus progestin and estrogen-alone women\u2019s health initiative clinical trials. Breast Cancer Res Treat. 2012;132(1):275\u201385.","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"2005_CR11","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s11864-003-0014-y","volume":"4","author":"CT Chung","year":"2003","unstructured":"Chung CT, Carlson RW. The role of aromatase inhibitors in early breast cancer. Curr Treat Options Oncol. 2003;4(2):133\u201340.","journal-title":"Curr Treat Options Oncol"},{"issue":"1\u20132","key":"2005_CR12","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.psychres.2006.04.013","volume":"151","author":"TM Michel","year":"2007","unstructured":"Michel TM, Frangou S, Thiemeyer D, Camara S, Jecel J, Nara K, Brunklaus A, Zoechling R, Riederer P. Evidence for oxidative stress in the frontal cortex in patients with recurrent depressive disorder\u2013a postmortem study. Psychiatry Res. 2007;151(1\u20132):145\u201350.","journal-title":"Psychiatry Res"},{"issue":"3","key":"2005_CR13","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/imm.12443","volume":"144","author":"N Bakunina","year":"2015","unstructured":"Bakunina N, Pariante CM, Zunszain PA. Immune mechanisms linked to depression via oxidative stress and neuroprogression. Immunology. 2015;144(3):365\u201373.","journal-title":"Immunology"},{"issue":"7","key":"2005_CR14","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.drudis.2020.05.001","volume":"25","author":"S Bhatt","year":"2020","unstructured":"Bhatt S, Nagappa AN, Patil CR. Role of oxidative stress in depression. Drug Discov Today. 2020;25(7):1270\u20136.","journal-title":"Drug Discov Today"},{"issue":"1","key":"2005_CR15","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/0006-291X(89)91757-9","volume":"164","author":"A Miyata","year":"1989","unstructured":"Miyata A, Arimura A, Dahl RR, Minamino N, Uehara A, Jiang L, Culler MD, Coy DH. Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem Biophys Res Commun. 1989;164(1):567\u201374.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"2005_CR16","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1124\/pr.109.001370","volume":"61","author":"D Vaudry","year":"2009","unstructured":"Vaudry D, Falluel-Morel A, Bourgault S, Basille M, Burel D, Wurtz O, Fournier A, Chow BK, Hashimoto H, Galas L, Vaudry H. Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery. Pharmacol Rev. 2009;61(3):283\u2013357.","journal-title":"Pharmacol Rev"},{"issue":"2","key":"2005_CR17","first-page":"269","volume":"52","author":"D Vaudry","year":"2000","unstructured":"Vaudry D, Gonzalez BJ, Basille M, Yon L, Fournier A, Vaudry H. Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions. Pharmacol Rev. 2000;52(2):269\u2013324.","journal-title":"Pharmacol Rev"},{"issue":"7335","key":"2005_CR18","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/nature09856","volume":"470","author":"KJ Ressler","year":"2011","unstructured":"Ressler KJ, Mercer KB, Bradley B, Jovanovic T, Mahan A, Kerley K, Norrholm SD, Kilaru V, Smith AK, Myers AJ, et al. Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor. Nature. 2011;470(7335):492\u20137.","journal-title":"Nature"},{"issue":"1","key":"2005_CR19","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1038\/s41467-019-11718-4","volume":"10","author":"T Yong","year":"2019","unstructured":"Yong T, Zhang X, Bie N, Zhang H, Zhang X, Li F, Hakeem A, Hu J, Gan L, Santos HA, Yang X. Tumor exosome-based nanoparticles are efficient drug carriers for chemotherapy. Nat Commun. 2019;10(1):3838.","journal-title":"Nat Commun"},{"issue":"2","key":"2005_CR20","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s12031-016-0731-x","volume":"59","author":"M Matsumoto","year":"2016","unstructured":"Matsumoto M, Nakamachi T, Watanabe J, Sugiyama K, Ohtaki H, Murai N, Sasaki S, Xu Z, Hashimoto H, Seki T, et al. Pituitary Adenylate cyclase-activating polypeptide (PACAP) is involved in adult mouse hippocampal neurogenesis after stroke. J Mol Neurosci. 2016;59(2):270\u20139.","journal-title":"J Mol Neurosci"},{"issue":"7","key":"2005_CR21","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1093\/brain\/awaa163","volume":"143","author":"G Baskozos","year":"2020","unstructured":"Baskozos G, Sandy-Hindmarch O, Clark AJ, Windsor K, Karlsson P, Weir GA, McDermott LA, Burchall J, Wiberg A, Furniss D, et al. Molecular and cellular correlates of human nerve regeneration: ADCYAP1\/PACAP enhance nerve outgrowth. Brain. 2020;143(7):2009\u201326.","journal-title":"Brain"},{"issue":"3","key":"2005_CR22","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.jaci.2021.02.005","volume":"148","author":"Y Yamamoto","year":"2021","unstructured":"Yamamoto Y, Otsuka A, Ishida Y, Wong LS, Seidel JA, Nonomura Y, Nakashima C, Nakajima S, Kitoh A, Nomura T, et al. Pituitary adenylate cyclase-activating polypeptide promotes cutaneous dendritic cell functions in contact hypersensitivity. J Allergy Clin Immunol. 2021;148(3):858\u201366.","journal-title":"J Allergy Clin Immunol"},{"key":"2005_CR23","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1917623117","author":"EY Lee","year":"2021","unstructured":"Lee EY, Chan LC, Wang H, Lieng J, Hung M, Srinivasan Y, Wang J, Waschek JA, Ferguson AL, Lee KF, et al. PACAP is a pathogen-inducible resident antimicrobial neuropeptide affording rapid and contextual molecular host defense of the brain. Proc Natl Acad Sci USA. 2021. https:\/\/doi.org\/10.1073\/pnas.1917623117.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2005_CR24","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/s12974-022-02639-z","volume":"19","author":"CA Figueiredo","year":"2022","unstructured":"Figueiredo CA, Dusedau HP, Steffen J, Ehrentraut S, Dunay MP, Toth G, Reglodi D, Heimesaat MM, Dunay IR. The neuropeptide PACAP alleviates T. gondii infection-induced neuroinflammation and neuronal impairment. J Neuroinflammation. 2022;19(1):274.","journal-title":"J Neuroinflammation"},{"issue":"2","key":"2005_CR25","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1161\/STROKEAHA.114.006864","volume":"46","author":"C Brifault","year":"2015","unstructured":"Brifault C, Gras M, Liot D, May V, Vaudry D, Wurtz O. Delayed pituitary adenylate cyclase-activating polypeptide delivery after brain stroke improves functional recovery by inducing m2 microglia\/macrophage polarization. Stroke. 2015;46(2):520\u20138.","journal-title":"Stroke"},{"issue":"8","key":"2005_CR26","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.biopsych.2016.08.025","volume":"81","author":"G Missig","year":"2017","unstructured":"Missig G, Mei L, Vizzard MA, Braas KM, Waschek JA, Ressler KJ, Hammack SE, May V. Parabrachial pituitary adenylate cyclase-activating polypeptide activation of amygdala endosomal extracellular signal-regulated kinase signaling regulates the emotional component of pain. Biol Psychiatry. 2017;81(8):671\u201382.","journal-title":"Biol Psychiatry"},{"issue":"12","key":"2005_CR27","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.biopsych.2015.06.013","volume":"80","author":"RJ Donahue","year":"2016","unstructured":"Donahue RJ, Venkataraman A, Carroll FI, Meloni EG, Carlezon WA Jr. Pituitary adenylate cyclase-activating polypeptide disrupts motivation, social interaction, and attention in male sprague dawley rats. Biol Psychiatry. 2016;80(12):955\u201364.","journal-title":"Biol Psychiatry"},{"issue":"12","key":"2005_CR28","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.biopsych.2014.12.018","volume":"78","author":"ST Pohlack","year":"2015","unstructured":"Pohlack ST, Nees F, Ruttorf M, Cacciaglia R, Winkelmann T, Schad LR, Witt SH, Rietschel M, Flor H. Neural mechanism of a sex-specific risk variant for posttraumatic stress disorder in the type I receptor of the pituitary adenylate cyclase activating polypeptide. Biol Psychiatry. 2015;78(12):840\u20137.","journal-title":"Biol Psychiatry"},{"issue":"2","key":"2005_CR29","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jconrel.2011.08.017","volume":"161","author":"S Wohlfart","year":"2012","unstructured":"Wohlfart S, Gelperina S, Kreuter J. Transport of drugs across the blood-brain barrier by nanoparticles. J Control Release. 2012;161(2):264\u201373.","journal-title":"J Control Release"},{"key":"2005_CR30","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.addr.2020.10.001","volume":"160","author":"A Duro-Castano","year":"2020","unstructured":"Duro-Castano A, Moreira Leite D, Forth J, Deng Y, Matias D, Noble Jesus C, Battaglia G. Designing peptide nanoparticles for efficient brain delivery. Adv Drug Deliv Rev. 2020;160:52\u201377.","journal-title":"Adv Drug Deliv Rev"},{"issue":"9","key":"2005_CR31","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/nrd4363","volume":"13","author":"S Mitragotri","year":"2014","unstructured":"Mitragotri S, Burke PA, Langer R. Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies. Nat Rev Drug Discov. 2014;13(9):655\u201372.","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"2005_CR32","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/hep.27420","volume":"61","author":"L Wang","year":"2015","unstructured":"Wang L, Liu X, Nie J, Zhang J, Kimball SR, Zhang H, Zhang WJ, Jefferson LS, Cheng Z, Ji Q, Shi Y. ALCAT1 controls mitochondrial etiology of fatty liver diseases, linking defective mitophagy to steatosis. Hepatology. 2015;61(2):486\u201396.","journal-title":"Hepatology"},{"issue":"26","key":"2005_CR33","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1002\/adma.201300638","volume":"25","author":"W Gao","year":"2013","unstructured":"Gao W, Hu CM, Fang RH, Luk BT, Su J, Zhang L. Surface functionalization of gold nanoparticles with red blood cell membranes. Adv Mater. 2013;25(26):3549\u201353.","journal-title":"Adv Mater"},{"issue":"2","key":"2005_CR34","doi-asserted-by":"crossref","first-page":"e292","DOI":"10.1002\/ctm2.292","volume":"11","author":"M Zhang","year":"2021","unstructured":"Zhang M, Cheng S, Jin Y, Zhang N, Wang Y. Membrane engineering of cell membrane biomimetic nanoparticles for nanoscale therapeutics. Clin Transl Med. 2021;11(2):e292.","journal-title":"Clin Transl Med"},{"issue":"22","key":"2005_CR35","doi-asserted-by":"crossref","first-page":"e2001704","DOI":"10.1002\/smll.202001704","volume":"16","author":"Q Jiang","year":"2020","unstructured":"Jiang Q, Wang K, Zhang X, Ouyang B, Liu H, Pang Z, Yang W. Platelet membrane-camouflaged magnetic nanoparticles for ferroptosis-enhanced Cancer Immunotherapy. Small. 2020;16(22):e2001704.","journal-title":"Small"},{"issue":"7","key":"2005_CR36","doi-asserted-by":"crossref","first-page":"5228","DOI":"10.1021\/acs.nanolett.0c01503","volume":"20","author":"X Xie","year":"2020","unstructured":"Xie X, Hu X, Li Q, Yin M, Song H, Hu J, Wang L, Fan C, Chen N. Unraveling cell-type-specific targeted delivery of membrane-camouflaged nanoparticles with Plasmonic Imaging. Nano Lett. 2020;20(7):5228\u201335.","journal-title":"Nano Lett"},{"key":"2005_CR37","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau6977","author":"R Kalluri","year":"2020","unstructured":"Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020. https:\/\/doi.org\/10.1126\/science.aau6977.","journal-title":"Science"},{"issue":"5","key":"2005_CR38","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1039\/C8SC03224F","volume":"10","author":"KL Zhang","year":"2019","unstructured":"Zhang KL, Wang YJ, Sun J, Zhou J, Xing C, Huang G, Li J, Yang H. Artificial chimeric exosomes for anti-phagocytosis and targeted cancer therapy. Chem Sci. 2019;10(5):1555\u201361.","journal-title":"Chem Sci"},{"key":"2005_CR39","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jconrel.2015.07.030","volume":"219","author":"EV Batrakova","year":"2015","unstructured":"Batrakova EV, Kim MS. Using exosomes, naturally-equipped nanocarriers, for drug delivery. J Control Release. 2015;219:396\u2013405.","journal-title":"J Control Release"},{"key":"2005_CR40","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.biomaterials.2017.10.012","volume":"150","author":"T Tian","year":"2018","unstructured":"Tian T, Zhang HX, He CP, Fan S, Zhu YL, Qi C, Huang NP, Xiao ZD, Lu ZH, Tannous BA, Gao J. Surface functionalized exosomes as targeted drug delivery vehicles for cerebral ischemia therapy. Biomaterials. 2018;150:137\u201349.","journal-title":"Biomaterials"},{"issue":"1","key":"2005_CR41","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12951-019-0563-2","volume":"18","author":"G Liang","year":"2020","unstructured":"Liang G, Zhu Y, Ali DJ, Tian T, Xu H, Si K, Sun B, Chen B, Xiao Z. Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer. J Nanobiotechnol. 2020;18(1):10.","journal-title":"J Nanobiotechnol"},{"key":"2005_CR42","doi-asserted-by":"crossref","first-page":"114895","DOI":"10.1016\/j.addr.2023.114895","volume":"198","author":"P Wen","year":"2023","unstructured":"Wen P, Ke W, Dirisala A, Toh K, Tanaka M, Li J. Stealth and pseudo-stealth nanocarriers. Adv Drug Deliv Rev. 2023;198:114895.","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"2005_CR43","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1021\/jacs.0c09029","volume":"143","author":"J Li","year":"2021","unstructured":"Li J, Kataoka K. Chemo-physical strategies to advance the in vivo functionality of targeted nanomedicine: the next generation. JACS. 2021;143(2):538\u201359.","journal-title":"JACS"},{"key":"2005_CR44","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jconrel.2015.03.033","volume":"207","author":"MJ Haney","year":"2015","unstructured":"Haney MJ, Klyachko NL, Zhao Y, Gupta R, Plotnikova EG, He Z, Patel T, Piroyan A, Sokolsky M, Kabanov AV, Batrakova EV. Exosomes as drug delivery vehicles for Parkinson\u2019s disease therapy. J Control Release. 2015;207:18\u201330.","journal-title":"J Control Release"},{"key":"2005_CR45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.addr.2019.11.009","volume":"165\u2013166","author":"R Pandit","year":"2020","unstructured":"Pandit R, Chen L, G\u00f6tz J. The blood-brain barrier: physiology and strategies for drug delivery. Adv Drug Deliv Rev. 2020;165\u2013166:1\u201314.","journal-title":"Adv Drug Deliv Rev"},{"key":"2005_CR46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2017.07.011","volume":"142","author":"D Yuan","year":"2017","unstructured":"Yuan D, Zhao Y, Banks WA, Bullock KM, Haney M, Batrakova E, Kabanov AV. Macrophage exosomes as natural nanocarriers for protein delivery to inflamed brain. Biomaterials. 2017;142:1\u201312.","journal-title":"Biomaterials"},{"issue":"40","key":"2005_CR47","doi-asserted-by":"crossref","first-page":"8472","DOI":"10.1039\/D1TB01116B","volume":"9","author":"K Zhang","year":"2021","unstructured":"Zhang K, Fu H, Xing C, Luo Y, Cheng F, Fu Q, Huang Y, Qiu L. Don\u2019t eat me\/eat me\u201d-combined apoptotic body analogues for efficient targeted therapy of triple-negative breast cancer. J Mater Chem B. 2021;9(40):8472\u20139.","journal-title":"J Mater Chem B"},{"issue":"17","key":"2005_CR48","doi-asserted-by":"crossref","first-page":"6161","DOI":"10.1039\/C5CS00199D","volume":"44","author":"M Molina","year":"2015","unstructured":"Molina M, Asadian-Birjand M, Balach J, Bergueiro J, Miceli E, Calder\u00f3n M. Stimuli-responsive nanogel composites and their application in nanomedicine. Chem Soc Rev. 2015;44(17):6161\u201386.","journal-title":"Chem Soc Rev"},{"key":"2005_CR49","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jconrel.2019.09.015","volume":"313","author":"MA Grimaudo","year":"2019","unstructured":"Grimaudo MA, Concheiro A, Alvarez-Lorenzo C. Nanogels for regenerative medicine. J Control Release. 2019;313:148\u201360.","journal-title":"J Control Release"},{"issue":"7","key":"2005_CR50","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.drudis.2018.05.018","volume":"23","author":"A Vashist","year":"2018","unstructured":"Vashist A, Kaushik A, Vashist A, Bala J, Nikkhah-Moshaie R, Sagar V, Nair M. Nanogels as potential drug nanocarriers for CNS drug delivery. Drug Discov Today. 2018;23(7):1436\u201343.","journal-title":"Drug Discov Today"},{"issue":"7","key":"2005_CR51","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.polymer.2007.01.068","volume":"48","author":"MHM Oudshoorn","year":"2007","unstructured":"Oudshoorn MHM, Rissmann R, Bouwstra JA, Hennink WE. Synthesis of methacrylated hyaluronic acid with tailored degree of substitution. Polymer. 2007;48(7):1915\u201320.","journal-title":"Polymer"},{"issue":"4","key":"2005_CR52","doi-asserted-by":"crossref","first-page":"e0215324","DOI":"10.1371\/journal.pone.0215324","volume":"14","author":"P Duong","year":"2019","unstructured":"Duong P, Chung A, Bouchareychas L, Raffai RL. Cushioned-density gradient ultracentrifugation (C-DGUC) improves the isolation efficiency of extracellular vesicles. PLoS ONE. 2019;14(4):e0215324.","journal-title":"PLoS ONE"},{"key":"2005_CR53","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.bbi.2020.06.019","volume":"88","author":"B Wang","year":"2020","unstructured":"Wang B, Huang X, Pan X, Zhang T, Hou C, Su WJ, Liu LL, Li JM, Wang YX. Minocycline prevents the depressive-like behavior through inhibiting the release of HMGB1 from microglia and neurons. Brain Behav Immun. 2020;88:132\u201343.","journal-title":"Brain Behav Immun"},{"issue":"1","key":"2005_CR54","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12974-020-01819-z","volume":"17","author":"N Goshi","year":"2020","unstructured":"Goshi N, Morgan RK, Lein PJ, Seker E. A primary neural cell culture model to study neuron, astrocyte, and microglia interactions in neuroinflammation. J Neuroinflammation. 2020;17(1):155.","journal-title":"J Neuroinflammation"},{"key":"2005_CR55","doi-asserted-by":"crossref","first-page":"153735","DOI":"10.1016\/j.phymed.2021.153735","volume":"92","author":"QS Wang","year":"2021","unstructured":"Wang QS, Yan K, Li KD, Gao LN, Wang X, Liu H, Zhang Z, Li K, Cui YL. Targeting hippocampal phospholipid and tryptophan metabolism for antidepressant-like effects of albiflorin. Phytomedicine. 2021;92:153735.","journal-title":"Phytomedicine"},{"issue":"1","key":"2005_CR56","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1038\/s41467-019-11641-8","volume":"10","author":"E Tunc-Ozcan","year":"2019","unstructured":"Tunc-Ozcan E, Peng CY, Zhu Y, Dunlop SR, Contractor A, Kessler JA. Activating newborn neurons suppresses depression and anxiety-like behaviors. Nat Commun. 2019;10(1):3768.","journal-title":"Nat Commun"},{"issue":"3","key":"2005_CR57","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.7150\/thno.65427","volume":"12","author":"K Sundaram","year":"2022","unstructured":"Sundaram K, Mu J, Kumar A, Behera J, Lei C, Sriwastva MK, Xu F, Dryden GW, Zhang L, Chen S, et al. Garlic exosome-like nanoparticles reverse high-fat diet induced obesity via the gut\/brain axis. Theranostics. 2022;12(3):1220\u201346.","journal-title":"Theranostics"},{"issue":"1","key":"2005_CR58","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s40168-019-0733-3","volume":"7","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Huang R, Cheng M, Wang L, Chao J, Li J, Zheng P, Xie P, Zhang Z, Yao H. Gut microbiota from NLRP3-deficient mice ameliorates depressive-like behaviors by regulating astrocyte dysfunction via circHIPK2. Microbiome. 2019;7(1):116.","journal-title":"Microbiome"},{"issue":"8","key":"2005_CR59","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.tiv.2009.07.009","volume":"23","author":"E Ferrer","year":"2009","unstructured":"Ferrer E, Juan-Garc\u00eda A, Font G, Ruiz MJ. Reactive oxygen species induced by beauvericin, patulin and zearalenone in CHO-K1 cells. Toxicol In Vitro. 2009;23(8):1504\u20139.","journal-title":"Toxicol In Vitro"},{"issue":"3","key":"2005_CR60","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.ecoenv.2008.01.018","volume":"72","author":"E Maran","year":"2009","unstructured":"Maran E, Fern\u00e1ndez M, Barbieri P, Font G, Ruiz MJ. Effects of four carbamate compounds on antioxidant parameters. Ecotoxicol Environ Saf. 2009;72(3):922\u201330.","journal-title":"Ecotoxicol Environ Saf"},{"key":"2005_CR61","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3389\/fncel.2015.00447","volume":"9","author":"E Brai","year":"2015","unstructured":"Brai E, Marathe S, Astori S, Fredj NB, Perry E, Lamy C, Scotti A, Alberi L. Notch1 regulates hippocampal plasticity through Interaction with the Reelin pathway, glutamatergic transmission and CREB signaling. Front Cell Neurosci. 2015;9:447.","journal-title":"Front Cell Neurosci"},{"issue":"7311","key":"2005_CR62","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nature09336","volume":"467","author":"V Nikoletopoulou","year":"2010","unstructured":"Nikoletopoulou V, Lickert H, Frade JM, Rencurel C, Giallonardo P, Zhang L, Bibel M, Barde YA. Neurotrophin receptors TrkA and TrkC cause neuronal death whereas TrkB does not. Nature. 2010;467(7311):59\u201363.","journal-title":"Nature"},{"issue":"3","key":"2005_CR63","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.neuron.2018.08.031","volume":"100","author":"L Leng","year":"2018","unstructured":"Leng L, Zhuang K, Liu Z, Huang C, Gao Y, Chen G, Lin H, Hu Y, Wu D, Shi M, et al. Menin Deficiency leads to depressive-like Behaviors in mice by modulating astrocyte-mediated neuroinflammation. Neuron. 2018;100(3):551\u2013563e557.","journal-title":"Neuron"},{"issue":"2","key":"2005_CR64","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/j.1471-4159.2009.06168.x","volume":"110","author":"H Hashimoto","year":"2009","unstructured":"Hashimoto H, Hashimoto R, Shintani N, Tanaka K, Yamamoto A, Hatanaka M, Guo X, Morita Y, Tanida M, Nagai K, et al. Depression-like behavior in the forced swimming test in PACAP-deficient mice: amelioration by the atypical antipsychotic risperidone. J Neurochem. 2009;110(2):595\u2013602.","journal-title":"J Neurochem"},{"key":"2005_CR65","doi-asserted-by":"crossref","first-page":"659783","DOI":"10.3389\/fcell.2021.659783","volume":"9","author":"T Wang","year":"2021","unstructured":"Wang T, Li Y, Guo M, Dong X, Liao M, Du M, Wang X, Yin H, Yan H. Exosome-mediated delivery of the neuroprotective peptide PACAP38 promotes retinal ganglion cell survival and axon regeneration in rats with traumatic optic neuropathy. Front Cell Dev Biol. 2021;9:659783.","journal-title":"Front Cell Dev Biol"},{"issue":"19","key":"2005_CR66","doi-asserted-by":"crossref","first-page":"8042","DOI":"10.1021\/acs.chemmater.7b02358","volume":"29","author":"B Illes","year":"2017","unstructured":"Illes B, Hirschle P, Barnert S, Cauda V, Wuttke S, Engelke H. Exosome-coated metal\u2013organic framework nanoparticles: an efficient drug delivery platform. Chem Mater. 2017;29(19):8042\u20136.","journal-title":"Chem Mater"},{"issue":"6","key":"2005_CR67","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.cell.2015.05.009","volume":"161","author":"Y Miao","year":"2015","unstructured":"Miao Y, Li G, Zhang X, Xu H, Abraham SN. A TRP Channel senses lysosome neutralization by pathogens to trigger their expulsion. Cell. 2015;161(6):1306\u201319.","journal-title":"Cell"},{"issue":"3","key":"2005_CR68","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1167\/iovs.08-2326","volume":"50","author":"EA Hoffman","year":"2009","unstructured":"Hoffman EA, Perkumas KM, Highstrom LM, Stamer WD. Regulation of myocilin-associated exosome release from human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 2009;50(3):1313\u20138.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"2005_CR69","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/glycob\/cwq171","volume":"21","author":"J Duan","year":"2011","unstructured":"Duan J, Kasper DL. Oxidative depolymerization of polysaccharides by reactive oxygen\/nitrogen species. Glycobiology. 2011;21(4):401\u20139.","journal-title":"Glycobiology"},{"key":"2005_CR70","doi-asserted-by":"crossref","first-page":"7062","DOI":"10.1038\/ncomms8062","volume":"6","author":"RC Bagot","year":"2015","unstructured":"Bagot RC, Parise EM, Pe\u00f1a CJ, Zhang HX, Maze I, Chaudhury D, Persaud B, Cachope R, Bola\u00f1os-Guzm\u00e1n CA, Cheer JF, et al. Ventral hippocampal afferents to the nucleus accumbens regulate susceptibility to depression. Nat Commun. 2015;6:7062.","journal-title":"Nat Commun"},{"issue":"51","key":"2005_CR71","doi-asserted-by":"crossref","first-page":"e1803717","DOI":"10.1002\/adma.201803717","volume":"30","author":"Y Zou","year":"2018","unstructured":"Zou Y, Liu Y, Yang Z, Zhang D, Lu Y, Zheng M, Xue X, Geng J, Chung R, Shi B. Effective and targeted human Orthotopic Glioblastoma Xenograft Therapy via a multifunctional biomimetic nanomedicine. Adv Mater. 2018;30(51):e1803717.","journal-title":"Adv Mater"},{"key":"2005_CR72","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.mattod.2020.02.001","volume":"37","author":"S Ding","year":"2020","unstructured":"Ding S, Khan AI, Cai X, Song Y, Lyu Z, Du D, Dutta P, Lin Y. Overcoming blood-brain barrier transport: advances in nanoparticle-based drug delivery strategies. Mater Today. 2020;37:112\u201325.","journal-title":"Mater Today"},{"issue":"12","key":"2005_CR73","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1038\/nm.3407","volume":"19","author":"B Obermeier","year":"2013","unstructured":"Obermeier B, Daneman R, Ransohoff RM. Development, maintenance and disruption of the blood-brain barrier. Nat Med. 2013;19(12):1584\u201396.","journal-title":"Nat Med"},{"issue":"7","key":"2005_CR74","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.addr.2011.11.010","volume":"64","author":"Y Chen","year":"2012","unstructured":"Chen Y, Liu L. Modern methods for delivery of drugs across the blood-brain barrier. Adv Drug Deliv Rev. 2012;64(7):640\u201365.","journal-title":"Adv Drug Deliv Rev"},{"key":"2005_CR75","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1743-8977-7-3","volume":"7","author":"S Bhaskar","year":"2010","unstructured":"Bhaskar S, Tian F, Stoeger T, Kreyling W, de la Fuente JM, Graz\u00fa V, Borm P, Estrada G, Ntziachristos V, Razansky D. Multifunctional nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging. Part Fibre Toxicol. 2010;7:3.","journal-title":"Part Fibre Toxicol"},{"key":"2005_CR76","first-page":"43","volume":"13","author":"YH Tsou","year":"2017","unstructured":"Tsou YH, Zhang XQ, Zhu H, Syed S, Xu X. Drug delivery to the brain across the blood-brain barrier using nanomaterials. Small. 2017;13:43.","journal-title":"Small"},{"key":"2005_CR77","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.addr.2013.08.008","volume":"71","author":"J Kreuter","year":"2014","unstructured":"Kreuter J. Drug delivery to the central nervous system by polymeric nanoparticles: what do we know? Adv Drug Deliv Rev. 2014;71:2\u201314.","journal-title":"Adv Drug Deliv Rev"},{"issue":"9","key":"2005_CR78","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1038\/s41551-021-00701-4","volume":"5","author":"S Chen","year":"2021","unstructured":"Chen S, Zhong Y, Fan W, Xiang J, Wang G, Zhou Q, Wang J, Geng Y, Sun R, Zhang Z, et al. Enhanced tumour penetration and prolonged circulation in blood of polyzwitterion-drug conjugates with cell-membrane affinity. Nat Biomed Eng. 2021;5(9):1019\u201337.","journal-title":"Nat Biomed Eng"},{"issue":"11","key":"2005_CR79","doi-asserted-by":"crossref","first-page":"10049","DOI":"10.1021\/acsnano.6b04695","volume":"10","author":"Z Chen","year":"2016","unstructured":"Chen Z, Zhao P, Luo Z, Zheng M, Tian H, Gong P, Gao G, Pan H, Liu L, Ma A, et al. Cancer cell membrane-biomimetic nanoparticles for homologous-targeting dual-modal imaging and photothermal therapy. ACS Nano. 2016;10(11):10049\u201357.","journal-title":"ACS Nano"},{"issue":"9","key":"2005_CR80","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.3330","volume":"33","author":"E Blanco","year":"2015","unstructured":"Blanco E, Shen H, Ferrari M. Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat Biotechnol. 2015;33(9):941\u201351.","journal-title":"Nat Biotechnol"},{"issue":"5","key":"2005_CR81","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.1021\/acsnano.9b00661","volume":"13","author":"Z Chai","year":"2019","unstructured":"Chai Z, Ran D, Lu L, Zhan C, Ruan H, Hu X, Xie C, Jiang K, Li J, Zhou J, et al. Ligand-modified cell membrane enables the targeted delivery of drug nanocrystals to Glioma. ACS Nano. 2019;13(5):5591\u2013601.","journal-title":"ACS Nano"},{"issue":"30","key":"2005_CR82","doi-asserted-by":"crossref","first-page":"2100722","DOI":"10.1002\/adfm.202100722","volume":"31","author":"A Zinger","year":"2021","unstructured":"Zinger A, Soriano S, Baudo G, De Rosa E, Taraballi F, Villapol S. Biomimetic nanoparticles as a theranostic tool for traumatic brain injury. Adv Funct Mater. 2021;31(30):2100722.","journal-title":"Adv Funct Mater"},{"issue":"6","key":"2005_CR83","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.1021\/acs.nanolett.8b04148","volume":"19","author":"N Perets","year":"2019","unstructured":"Perets N, Betzer O, Shapira R, Brenstein S, Angel A, Sadan T, Ashery U, Popovtzer R, Offen D. Golden exosomes selectively target brain pathologies in neurodegenerative and neurodevelopmental disorders. Nano Lett. 2019;19(6):3422\u201331.","journal-title":"Nano Lett"},{"issue":"1","key":"2005_CR84","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41556-018-0250-9","volume":"21","author":"M Mathieu","year":"2019","unstructured":"Mathieu M, Martin-Jaular L, Lavieu G, Th\u00e9ry C. Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication. Nat Cell Biol. 2019;21(1):9\u201317.","journal-title":"Nat Cell Biol"},{"key":"2005_CR85","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.neubiorev.2017.08.019","volume":"84","author":"H Akil","year":"2018","unstructured":"Akil H, Gordon J, Hen R, Javitch J, Mayberg H, McEwen B, Meaney MJ, Nestler EJ. Treatment resistant depression: a multi-scale, systems biology approach. Neurosci Biobehav Rev. 2018;84:272\u201388.","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"2005_CR86","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ijpharm.2009.06.019","volume":"379","author":"A Mistry","year":"2009","unstructured":"Mistry A, Stolnik S, Illum L. Nanoparticles for direct nose-to-brain delivery of drugs. Int J Pharm. 2009;379(1):146\u201357.","journal-title":"Int J Pharm"},{"issue":"1","key":"2005_CR87","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s10194-018-0855-1","volume":"19","author":"T Hirabayashi","year":"2018","unstructured":"Hirabayashi T, Nakamachi T, Shioda S. Discovery of PACAP and its receptors in the brain. J Headache Pain. 2018;19(1):28.","journal-title":"J Headache Pain"},{"issue":"12","key":"2005_CR88","doi-asserted-by":"crossref","first-page":"e978","DOI":"10.1038\/tp.2016.241","volume":"6","author":"KB Mercer","year":"2016","unstructured":"Mercer KB, Dias B, Shafer D, Maddox SA, Mulle JG, Hu P, Walton J, Ressler KJ. Functional evaluation of a PTSD-associated genetic variant: estradiol regulation and ADCYAP1R1. Transl Psychiatry. 2016;6(12):e978.","journal-title":"Transl Psychiatry"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-023-02005-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-023-02005-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-023-02005-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T19:22:47Z","timestamp":1700248967000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-023-02005-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,8]]},"references-count":88,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2005"],"URL":"https:\/\/doi.org\/10.1186\/s12951-023-02005-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2820080\/v1","asserted-by":"object"}]},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,8]]},"assertion":[{"value":"15 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The protocols were carried out in accordance with the principles for laboratory animals (U.K. Animals Act and associated guidelines, 1986). All experiments involving animals were conducted according to the ethical policies and procedures approved by the Institutional Animal Care and Use Committee at Nanjing University of Chinese medicine (No. 202112A046), Nanjing University of Chinese medicine, China.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"261"}}